Navigation Links
Indiana Biosciences Research Institute Hits $50 Million Start-Up Funding Goal
Date:11/19/2013

INDIANAPOLIS, Nov. 19, 2013 /PRNewswire/ -- The Indiana Biosciences Research Institute announced today that it has reached the first $50 million funding milestone, fueling continued momentum in the development of the nation's first industry-led biosciences research institute.

Officially launched in a public announcement on May 30 by Indiana Governor Mike Pence with leading Hoosier companies and universities, the research institute serves as the catalyst to advancing the state's life sciences strengths. The Institute, which will attract world-class scientific leaders and research dollars to Indiana, will accelerate collaboration across and among Indiana's substantial academic and commercial research assets while focusing on human health solutions for improving the lives of Hoosiers and people around the world.

In less than 5 months, the Indiana Biosciences Research Institute has raised $25 million from corporate and philanthropic funders, matching the $25 million appropriated by the Indiana General Assembly earlier this year.

Eli Lilly and Company, whose Chairman and CEO, John Lechleiter, Ph.D., joined Governor Pence in 2012 in calling for the establishment of a biosciences research institute, has committed $7.5 million in start-up funding.

"Today's announcement represents a significant investment by Lilly in the future of Indiana and in the future of biosciences research," Lechleiter said. "Each year in Indiana, billions of dollars are invested in research and development to advance medical innovation. This Institute will help Indiana attract additional global talent and will nurture partnerships across the state and across the country - keeping more research dollars in Indiana and attracting more federal research funds to our state.

"In the last decade, Indiana has come of age as a recognized leader in the life sciences - with demonstrated capabilities in biopharmaceuticals, medical devices, and diagnostics, as well as in the areas of animal health and crop sciences. The research institute will fuel Indiana's economy and will underscore the state's position as a life sciences leader. The bio-landscape of Indiana is fertile ground for the Institute, and Lilly is proud to be a part of it."

An additional $4.5 million in start-up funding comes from Roche Diagnostics, with additional funding from Dow AgroSciences, Indiana University Health and Indiana University.

"The Indiana Biosciences Research Institute is one of the most dramatic demonstrations of how well our State leverages its strengths for widespread benefit," said Jack Phillips, president and CEO of Roche Diagnostics. "Not only have our State leadership and corporate partners committed financial resources to the Institute, but they have worked closely with our university partners and others to ensure we build an institute that is unlike any in the nation." 

The $50 million in funding better positions the Institute to recruit a world-class CEO, attract outstanding scientific talent, successfully initiate its scientific activities and organize the next phase of the capital campaign. The Indiana Biosciences Research Institute board of directors officially launched its CEO search in September and has made significant progress in collaboration with its university partners in defining its university engagement frameworks for intellectual property, Indiana Fellow university affiliations, and core laboratory access and use.  

"The development of the Indiana Biosciences Research Institute is rapidly progressing due to the overwhelming support and collaboration of the State of Indiana, and statewide corporate, philanthropic and academic partners," said David Johnson, president and CEO of BioCrossroads. "The Institute is a centerpiece project of BioCrossroads, an initiative that advances the state's life sciences strengths, and is an example on a grand level of how collaboration builds our life sciences leadership position."

The estimated $360-million Indiana Biosciences Research Institute is a non-profit entity. The $50 million in start-up funding will be followed by a campaign to raise an additional $310 million in corporate and philanthropic funding to support further Institute development and operating costs. Long-term, Institute operating costs will be funded through the development of the Institute's own endowment, industry-sponsored research and federally funded research.

As part of the Institute's development process, industry leaders have defined common scientific interests for research and discovery. The Institute will initially focus on the most pressing issues of human health: cardiovascular disease, diabetes, obesity and nutrition. These interrelated metabolic disorders are a major economic burden and a leading cause of death in the United States. Approximately 35 percent of Americans suffer from cardiovascular disease and metabolic disorders, including a disproportionate percentage of Hoosiers who suffer from these diseases.

About the Indiana Biosciences Research Institute 
The Indiana Biosciences Research Institute was incorporated in May 2013 and is the first industry-led biosciences research institute in the nation. The Institute is being developed by industry executives from Eli Lilly and Company, Dow AgroSciences, Roche Diagnostics, Cook Medical, Indiana University Health and Biomet, the Governor of Indiana, with active support in initial development by BioCrossroads. Indiana's research institutions, including Indiana University, Purdue University and the University of Notre Dame also are participating in the development process. More information about the Indiana Biosciences Research Institute can be found at www.indianabiosciences.org.


'/>"/>
SOURCE Indiana Biosciences Research Institute
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Indiana leads U.S. in life sciences jobs and growth
2. Indianas Stop-Sale System Achieves Significant Results In Battle Against Meth
3. Lilly to Expand Indianapolis Insulin Manufacturing Operations
4. CHPA Statement on Statewide Indiana Consumer Poll
5. Contract Manufacturer RMI hosts Central Indiana Jobs Roundtable with U.S. Senator Joe Donnelly
6. Lilly Statement on Indiana Biosciences Research Institute
7. Lilly to host investment community meeting at its Indianapolis headquarters on Thursday, October 3, 2013
8. 1,200th Worldwide Implant of the SynCardia Total Artificial Heart Occurs in Indiana
9. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
10. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
11. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , Jan. 19, 2017 This report on ... and future scenario of the global market. Large number ... consumption. Severe chronic constipation is a major side effect ... laxatives. Hence, novel targeted therapy has been prescribed to ... launch of targeted medicines, and growing awareness about the ...
(Date:1/19/2017)... NEW YORK , January 19, 2017 ... global market for cryotherapy is set to witness a CAGR of ... North America will continue to be the leading ... ... Suppliers are emphasizing on ensuring affordable and adequate supply ...
(Date:1/19/2017)... Fla. , Jan. 19, 2017  Sensus ... medical device company specializing in the treatment of ... as keloids, with superficial radiation therapy, today announced ... full year 2016 financial results on Thursday, February 2, ... Company will hold a conference call with the ...
Breaking Medicine Technology:
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... highest level of nutritional and bodybuilding supplements, announced it attended the January ECRM trade ... a respected bodybuilder and nutritional scientist who was determined to create a line of ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is Greater than ... the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” ... career as an educator interacting with countless women who had little knowledge of the ...
(Date:1/20/2017)... ... 2017 , ... D R Burton Healthcare Products LLC, makers ... in a study indicating superior performance against competitive products in secretion clearance. ... Positive Expiratory Pressure Devices During Simulated Breathing“ was published in the winter issue ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Land of More and More”: a ... world hunger, and shares the simple and achievable answer. “The Land of More and ... the Fairview Missionary Church in Angola, Indiana where he works with the children’s ministry ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... Next week ... will be repealed by Congressional political games that circumvent health needs of over 30 ... Rally” capture the human anxieties and needs government public servants were suppose to prioritize. ...
Breaking Medicine News(10 mins):